Peregrine Ventures

Cordio Medical LTD. is an Israeli company founded in 2013, specializing in the development of a mobile application aimed at monitoring patients with congestive heart failure. The company's innovative platform utilizes advanced speech processing technology to enable near real-time monitoring and early detection of health condition deterioration through patients' voices. By leveraging machine learning capabilities, Cordio's solution allows healthcare providers to identify potential issues and intervene proactively, thereby mitigating the risk of patient deterioration and hospitalization. The focus remains on enhancing patient well-being while providing physicians with valuable insights to improve care management.

Blue White Robotics Ltd, established in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing a robot-as-a-service (RaaS) software platform that facilitates the operation of multiple autonomous systems. The company provides solutions that enable centralized command and control of various unmanned vehicles, including drones and ground robots, across diverse industries such as agriculture, mining, construction, energy, urban mobility, and public safety. Their technology is utilized for applications including data collection, crop treatment, security, mapping, and autonomous transport. Blue White Robotics focuses on testing and licensing autonomous systems, employing specialized equipment to ensure reliable performance. With a founding team of former Israeli Air Force pilots and engineers, the company has experienced significant growth, positioning itself as a leader in the adoption of autonomous technologies.

BrainQ Technolgies Ltd, a clinical-stage medtech company, develops brain-machine induction technologies to provide personalized, safe, and noninvasive treatments for neuro-disorders including stroke, traumatic brain injury, and spinal cord injury. It offers a cloud-based medical device that utilizes artificial intelligence to analyze patients’ EEG sensor data. The company was founded in 2011 and is based in Jerusalem, Israel.

Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

KAHR Medical Ltd. is an immuno-oncology drug development company based in Jerusalem, Israel, founded in 2005. The company focuses on creating fusion protein pharmaceuticals aimed at treating cancer and autoimmune diseases. KAHR develops innovative drugs such as DSP105 and DSP106, which facilitate T-cell mediated tumor destruction, and DSP107, which targets CD47 tumors to activate phagocytes while delivering an immune costimulatory signal. Utilizing a unique platform of multifunctional immuno-recruitment proteins, KAHR's technology aims to enhance immune system recognition of cancer cells, thereby addressing the challenge of cancer evasion. This approach represents a significant advancement in protein-based pharmaceuticals, expanding treatment options for patients facing these serious health conditions.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

OutSense Diagnostics is an innovative company based in Or Yehuda, Israel, established in 2016. The company specializes in the development of a medical device designed for the early detection of various health conditions through the analysis of human waste in a standard toilet bowl. Utilizing advanced imaging technologies, OutSense's IoT sensor generates daily medical status reports based on biological excretions, alerting caregivers to any health deviations. The device aims to monitor essential health parameters and is particularly focused on preventing colorectal cancer by detecting hidden blood in stool, a critical screening method currently reliant on laboratory analysis of stool samples. In addition to colorectal cancer, the device has applications for monitoring conditions such as urinary tract infections, diarrhea, dehydration, and constipation.

BioProtect Ltd. is an international medical device startup focused on developing and commercializing biodegradable balloon spacers designed to protect normal tissue during cancer radiation therapy. The company's flagship product, the ProSpace balloon spacer, has demonstrated superior efficacy and safety in safeguarding the rectum during radiation treatment for prostate cancer. This innovative technology significantly reduces the risk of serious and chronic side effects associated with radiation, while enhancing tumor control. Founded in 2004 and headquartered in Israel, BioProtect also operates subsidiaries in Germany and the United States, aiming to address unmet clinical needs in the growing radiotherapy spacers market with its platform of biodegradable implantable balloons.

Blue White Robotics Ltd, established in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing a robot-as-a-service (RaaS) software platform that facilitates the operation of multiple autonomous systems. The company provides solutions that enable centralized command and control of various unmanned vehicles, including drones and ground robots, across diverse industries such as agriculture, mining, construction, energy, urban mobility, and public safety. Their technology is utilized for applications including data collection, crop treatment, security, mapping, and autonomous transport. Blue White Robotics focuses on testing and licensing autonomous systems, employing specialized equipment to ensure reliable performance. With a founding team of former Israeli Air Force pilots and engineers, the company has experienced significant growth, positioning itself as a leader in the adoption of autonomous technologies.

OutSense Diagnostics is an innovative company based in Or Yehuda, Israel, established in 2016. The company specializes in the development of a medical device designed for the early detection of various health conditions through the analysis of human waste in a standard toilet bowl. Utilizing advanced imaging technologies, OutSense's IoT sensor generates daily medical status reports based on biological excretions, alerting caregivers to any health deviations. The device aims to monitor essential health parameters and is particularly focused on preventing colorectal cancer by detecting hidden blood in stool, a critical screening method currently reliant on laboratory analysis of stool samples. In addition to colorectal cancer, the device has applications for monitoring conditions such as urinary tract infections, diarrhea, dehydration, and constipation.

DOKKA automates the collection of documents, the extraction of data from invoices, creation of bookkeeping entries and reconciliations.

Loadmill is a developer of an automated testing tool that enhances the quality assurance process for businesses. The tool allows companies to utilize live user sessions to create and execute advanced test scenarios efficiently. By recording and replaying real user behavior, Loadmill automates the generation of regression tests, significantly reducing the time and effort needed for manual testing. This capability enables companies to identify and address critical performance issues before production, ensuring a smoother deployment process. With its focus on automating quality assurance, Loadmill aims to increase testing velocity and improve overall software reliability.

Hairstetics Ltd. is a healthcare company based in Omer, Israel, specializing in the development, manufacturing, and marketing of innovative hair restoration devices. Founded in 2010, the company focuses on creating multiple-hair implantation devices designed to address hair loss issues. Its products aim to simplify the implantation procedure, reduce recovery time, and deliver superior aesthetic results at a lower cost compared to traditional hair restoration methods. By providing advanced treatment options, Hairstetics seeks to assist individuals dealing with hair fall problems.

Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

Restore Medical develops and provides a device-based therapy for congestive heart failure. It improves patient quality of life and reduce hospital readmission rates. Restore Medical's product, ContraBand, is a novel catheter-delivered implant in the pulmonary arteries for treatment of left ventricle failure, for patients with preserved right ventricle function. Restore Medical was founded in 2016 and is headquartered in Or Yehuda, Israel.

Raziel Health is focused on developing innovative treatments for obesity and fat disorders, particularly through its injectable drug RZL-012. This novel synthetic small molecule is designed to be injected directly into fat tissue, where it induces fat cell death, leading to a reduction in fat at the injection site. The company, founded in 2012 and based in Rehovot, Israel, aims to provide accessible and cost-effective healthcare solutions that enhance patient experience and promote timely clinical interventions. By integrating user-friendly technologies and leveraging data analytics, Raziel Health supports wellness and disease management, ensuring that individual patient goals are met effectively.

Raziel Health is focused on developing innovative treatments for obesity and fat disorders, particularly through its injectable drug RZL-012. This novel synthetic small molecule is designed to be injected directly into fat tissue, where it induces fat cell death, leading to a reduction in fat at the injection site. The company, founded in 2012 and based in Rehovot, Israel, aims to provide accessible and cost-effective healthcare solutions that enhance patient experience and promote timely clinical interventions. By integrating user-friendly technologies and leveraging data analytics, Raziel Health supports wellness and disease management, ensuring that individual patient goals are met effectively.

Roby.ai offers an artificial intelligence assistant tailored for rental agencies and property managers, designed to streamline property management tasks with minimal human intervention. The platform automates various time-consuming and manual activities, allowing property managers to enhance efficiency and improve compliance while significantly reducing costs. By utilizing push notifications via SMS and email, Roby.ai facilitates user engagement throughout the rental process, making interactions smoother for both managers and clients. This bespoke automation software addresses the complexities of property management, enabling users to focus on strategic activities rather than mundane tasks. Overall, Roby.ai aims to transform the rental management landscape by providing a comprehensive solution that increases operational efficiency and effectiveness.

Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

Kymera Labs develops synthetic data to securely process your confidential information.

Loadmill is a developer of an automated testing tool that enhances the quality assurance process for businesses. The tool allows companies to utilize live user sessions to create and execute advanced test scenarios efficiently. By recording and replaying real user behavior, Loadmill automates the generation of regression tests, significantly reducing the time and effort needed for manual testing. This capability enables companies to identify and address critical performance issues before production, ensuring a smoother deployment process. With its focus on automating quality assurance, Loadmill aims to increase testing velocity and improve overall software reliability.

Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Hairstetics Ltd. is a healthcare company based in Omer, Israel, specializing in the development, manufacturing, and marketing of innovative hair restoration devices. Founded in 2010, the company focuses on creating multiple-hair implantation devices designed to address hair loss issues. Its products aim to simplify the implantation procedure, reduce recovery time, and deliver superior aesthetic results at a lower cost compared to traditional hair restoration methods. By providing advanced treatment options, Hairstetics seeks to assist individuals dealing with hair fall problems.

CliClap LTD develops content marketing utility for web browsers. It enables users to boost audience engagement, brand awareness and drive business goals. Additionaly, the products add users call to action, schedule their posts, analyze the success. The company was founded in 2016 and is based in Kfar Saba, Israel.

CliClap LTD develops content marketing utility for web browsers. It enables users to boost audience engagement, brand awareness and drive business goals. Additionaly, the products add users call to action, schedule their posts, analyze the success. The company was founded in 2016 and is based in Kfar Saba, Israel.

DOKKA automates the collection of documents, the extraction of data from invoices, creation of bookkeeping entries and reconciliations.

Payzday is a risk management solution provider based in Tel Aviv, Israel, established in 2017. The company specializes in analyzing the risk levels of merchants selling online through marketplaces. By leveraging advanced technologies such as big data, artificial intelligence, and predictive analytics, Payzday creates significant visibility into the risk associated with these merchants. Its approach extends beyond initial onboarding assessments, offering continuous monitoring that enables near real-time predictions of any potentially unlawful, risky, or unstable situations involving merchants. This innovative methodology allows financial institutions to make informed decisions and provide necessary financing solutions to online sellers, ultimately aiming to enhance their access to capital.

Cordio Medical LTD. is an Israeli company founded in 2013, specializing in the development of a mobile application aimed at monitoring patients with congestive heart failure. The company's innovative platform utilizes advanced speech processing technology to enable near real-time monitoring and early detection of health condition deterioration through patients' voices. By leveraging machine learning capabilities, Cordio's solution allows healthcare providers to identify potential issues and intervene proactively, thereby mitigating the risk of patient deterioration and hospitalization. The focus remains on enhancing patient well-being while providing physicians with valuable insights to improve care management.

Cordio Medical LTD. is an Israeli company founded in 2013, specializing in the development of a mobile application aimed at monitoring patients with congestive heart failure. The company's innovative platform utilizes advanced speech processing technology to enable near real-time monitoring and early detection of health condition deterioration through patients' voices. By leveraging machine learning capabilities, Cordio's solution allows healthcare providers to identify potential issues and intervene proactively, thereby mitigating the risk of patient deterioration and hospitalization. The focus remains on enhancing patient well-being while providing physicians with valuable insights to improve care management.

Digma Medical is a clinical stage medical device company established in 2013, focused on innovating treatments for Type-2 Diabetes and related metabolic syndromes, including NASH. The company is developing the DiaGone™, an endoscopic and disposable device that employs advanced laser technology to treat the duodenum without the need for an implant. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to use the DiaGone™ to enhance the body's ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and other metabolic conditions, thereby improving their overall quality of life and health outcomes. Supported by prominent venture capital firms, Digma Medical is dedicated to advancing effective therapies for diabetes management.

Rise.ai is a strategic re-engagement solution that provides brands and retailers with a unique currency of their own. Powered by Artificial Intelligence, Rise.ai helps merchants grow by retaining customers and increasing their average spending.

OutSense Diagnostics is an innovative company based in Or Yehuda, Israel, established in 2016. The company specializes in the development of a medical device designed for the early detection of various health conditions through the analysis of human waste in a standard toilet bowl. Utilizing advanced imaging technologies, OutSense's IoT sensor generates daily medical status reports based on biological excretions, alerting caregivers to any health deviations. The device aims to monitor essential health parameters and is particularly focused on preventing colorectal cancer by detecting hidden blood in stool, a critical screening method currently reliant on laboratory analysis of stool samples. In addition to colorectal cancer, the device has applications for monitoring conditions such as urinary tract infections, diarrhea, dehydration, and constipation.

NeuroApplied offers customer-focused marketing based on the study of the customers’ collective subconscious. The company applies machine-learning analytics, in combination with neural-networks computing, to online picture games in order to provide its clients with useful data collected from the associative subconscious of their customers. Its SaaS-based platform provides an intuitive dashboard for insights that is nonintrusive, and visually stimulating for respondents. NeuroApplied was founded by Lior Moyal, Elhanan Meirovithz, and Inna Schneiderman in June 2016.

NeuroApplied offers customer-focused marketing based on the study of the customers’ collective subconscious. The company applies machine-learning analytics, in combination with neural-networks computing, to online picture games in order to provide its clients with useful data collected from the associative subconscious of their customers. Its SaaS-based platform provides an intuitive dashboard for insights that is nonintrusive, and visually stimulating for respondents. NeuroApplied was founded by Lior Moyal, Elhanan Meirovithz, and Inna Schneiderman in June 2016.

Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.

Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

mPharma Data, Inc. is a technology-driven company based in Accra, Ghana, with an additional location in Lexington, Massachusetts. Founded in 2013, it focuses on improving access to high-quality medications in emerging markets by connecting physicians, pharmacies, and patients through its application. The company aggregates real-time market data on prescription trends, drug consumption, and adverse reactions, providing valuable insights to pharmaceutical manufacturers, distributors, and governments. mPharma offers a pharmacy network application that centralizes inventories from multiple pharmacies, enabling easier drug searches for physicians and patients. Additionally, the company provides subscription-based data analytics for actionable insights on drug consumption and diagnosis, along with prescription management tools to assist healthcare providers in locating various medicines. By partnering with drug manufacturers, insurance companies, and governments, mPharma aims to facilitate affordable access to essential medications for patients.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Evolero Ltd. specializes in event management software solutions tailored for event organizers and meeting planners. Founded in 2011 and headquartered in Herzliya, Israel, the company provides a comprehensive platform that facilitates online conference planning and organization. Evolero's software enables users to sell tickets online, manage event ticketing and registration, and offers sponsors advanced marketing tools. Additionally, it equips attendees with networking capabilities, all within a single platform. By integrating various functionalities, Evolero supports meeting planners and congress organizers in creating effective event websites and enhancing social media engagement for improved networking opportunities.

Yotta Green offers an innovative smart home system that focuses on improving energy efficiency, comfort, and safety through advanced monitoring technologies. By analyzing household power consumption and learning consumer behavior patterns, the system provides valuable insights into energy usage. It alerts users to potential energy waste and electrical hazards, such as fires, and can automatically turn off unused lights and appliances. Additionally, the system can take proactive measures, like lowering blinds before a storm, to enhance home safety. Yotta Green's user-friendly interface, accessible via a smartphone app along with touch and gesture activation devices, ensures maximum convenience for homeowners seeking to optimize their energy consumption and maintain a secure living environment.

Cordio Medical LTD. is an Israeli company founded in 2013, specializing in the development of a mobile application aimed at monitoring patients with congestive heart failure. The company's innovative platform utilizes advanced speech processing technology to enable near real-time monitoring and early detection of health condition deterioration through patients' voices. By leveraging machine learning capabilities, Cordio's solution allows healthcare providers to identify potential issues and intervene proactively, thereby mitigating the risk of patient deterioration and hospitalization. The focus remains on enhancing patient well-being while providing physicians with valuable insights to improve care management.

ShapeDo Ltd., founded in 2014 and based in Modi'in-Maccabim-Re'ut, Israel, specializes in developing software solutions that address the complexities of managing plan changes in construction projects. Its software is designed to ensure that any modifications to plans are accurately reflected in contracts, budgets, and related agreements. The platform enables users to track and compare blueprint versions, while also facilitating the creation of essential documents such as court-ready pricing reports, requests for information, and claims. ShapeDo has been involved in significant infrastructure projects, including a new international airport, an underground train, hospitals, and data centers, while also catering to smaller commercial and residential developments.

Zuznow specializes in mobile adaptation solutions for websites, providing a platform that automatically analyzes and adjusts the visual structure of desktop sites for optimal viewing on smartphones. Founded in 2009 and based in Israel, the company serves a diverse clientele, including notable names such as VentureBeat, HOOP, Newsgeek, and BAKER TILLY. Zuznow's rapid mobile application development (RMAD) platform operates as a Front-end-as-a-Service (FAAS), facilitating the creation of secure mobile applications for B2B, B2C, and B2E enterprises. This hybrid platform is designed to streamline the adaptation of complex websites, significantly reducing development time and costs while meeting the increasing demand for mobile functionality.

Jobrain Ltd. offers a cloud-based hiring software that streamlines the recruitment process for HR teams and candidates alike. Based in Herzliya, Israel, Jobrain's platform enables candidates to apply for jobs conveniently and assists HR professionals in quickly identifying and hiring the best talent. The software features an open marketplace that provides access to various talent acquisition services, including job post distribution, remote interviewing, one-way video interviews, and candidate assessments. Jobrain serves a diverse clientele, including head-hunters, agencies, job boards, and hiring services, all while leveraging data science to enhance hiring success and improve collaboration among hiring teams. By simplifying the recruitment process through a user-friendly interface, Jobrain allows organizations to focus on essential tasks rather than administrative paperwork.

Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

Marketyze is a technology company specializing in semantic site search and online price comparison solutions, primarily serving the retail industry. Founded in December 2011 by Onn Manelson and Nave Ronen, the company is based in Israel. Marketyze's pricing intelligence software collects and examines pricing, market, and internal data to assess the impact of pricing events on sales performance. This analysis enables retailers to refine their pricing strategies, ultimately aiming to enhance both sales and profitability. Additionally, Marketyze provides a cloud-based platform that monitors and evaluates product prices among competitors, delivering essential pricing data and analytics to online retailers.

Evolero Ltd. specializes in event management software solutions tailored for event organizers and meeting planners. Founded in 2011 and headquartered in Herzliya, Israel, the company provides a comprehensive platform that facilitates online conference planning and organization. Evolero's software enables users to sell tickets online, manage event ticketing and registration, and offers sponsors advanced marketing tools. Additionally, it equips attendees with networking capabilities, all within a single platform. By integrating various functionalities, Evolero supports meeting planners and congress organizers in creating effective event websites and enhancing social media engagement for improved networking opportunities.

ArTack Medical is a privately held medical device company based in Haifa, Israel, founded in 2013. The company specializes in developing innovative tools for the invasive surgery market, particularly focusing on hernia repair. ArTack Medical's flagship product is an articulated hernia mesh fixation device designed to facilitate both laparoscopic and open surgical procedures. This device is compatible with any currently available mesh and allows surgeons to maintain their standard techniques without modification. The company’s patented drive platform enables the delivery of torque through a 5mm shaft, enhancing the effectiveness and ease of surgical interventions.

Mend specializes in open-source software (OSS) lifecycle management solutions, offering a comprehensive cloud-based platform designed to manage the OSS lifecycle effectively. Their flagship product integrates seamlessly with development environments and DevOps pipelines, enabling real-time detection of open-source libraries that may pose security or compliance risks. Mend provides actionable remediation paths to resolve identified issues quickly and enforces automated policies to streamline the fixing process. The platform supports over 200 programming languages and continuously monitors multiple open-source vulnerability databases, ensuring that users are informed of potential risks while minimizing false positives. Founded in 2011 and headquartered in New York, Mend maintains additional offices in Boston, Givatayim, the United Kingdom, and Switzerland.

Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.

Peak-Dynamics is a research-driven technology company focused on enhancing the efficiency of water utility operations. It has developed PeakWater, a sophisticated software platform that integrates with existing SCADA systems to monitor and optimize energy usage and water delivery processes. The platform employs the Optimized Stochastic Search Algorithm (OSSA) to provide water utilities with insights that lead to significant energy savings and cost reductions. A distinctive feature of PeakWater is its capability to analyze energy supplier tariffs, allowing water authorities to navigate the competitive energy market effectively while meeting contractual obligations. This positions Peak-Dynamics as a pioneer in the Water-Energy Nexus, offering a unique solution that combines water system management with energy procurement optimization. The company markets its innovative services to water management companies, municipal authorities, and regional entities, delivering enhanced reliability and operational cost savings. With a team of skilled professionals in software development, sales, and water system modeling, Peak-Dynamics is well-equipped for expansion, including a recent establishment of operations in the United States.

CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries. The system is composed of a double-lumen cannula in which the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for the filtration.

Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com

Valire is a software solution company based in HaMerkaz, Israel, specializing in artificial intelligence applications for fraud detection and risk management. Founded in 2009, Valire develops tools that assess fraud risk, validate business processes, and create tailored algorithms to help organizations secure their revenue. By integrating business rules with symbolic machine learning, Valire's software effectively identifies fraudulent behavior while minimizing false positives and ensuring cost-effective implementation. This approach allows businesses to reduce operational risks and enhance performance, ultimately supporting their growth opportunities.

QuickLizard is a technology provider specializing in dynamic pricing solutions for e-commerce and omnichannel retailers. Its platform utilizes artificial intelligence to monitor and analyze real-time market trends, enabling businesses to set optimal prices based on competitive landscapes, customer behavior, and demand fluctuations. By continuously adapting to market changes, QuickLizard helps retailers maximize sales volume and enhance revenue, with reported increases of up to 30%. The platform integrates seamlessly with various commerce, retail, and ERP systems, ensuring that pricing recommendations are automatically synchronized and applied.

Rocketick Technologies Ltd., founded in 2008 and based in Ramat Gan, Israel, specializes in GPU-based simulation acceleration solutions aimed at enhancing chip verification processes. The company's flagship product, RocketSim, is a software-based simulation engine that integrates within existing simulator environments. It effectively addresses functional verification bottlenecks by providing GPU acceleration, resulting in simulations that are up to ten times faster for complex designs. RocketSim has gained traction among various semiconductor clients, establishing Rocketick as a pioneer in the field of hardware-assisted acceleration. Since April 2016, Rocketick has operated as a subsidiary of Cadence Design Systems Inc.

Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

Cellvine specializes in developing and marketing advanced solutions for the wireless telecommunications industry, focusing on enhancing cellular coverage and capacity. The company offers a diverse range of products designed to improve cellular signals in various environments, including urban areas, rural locations, and specialized settings such as mines and tunnels. Utilizing exclusive technology, Cellvine addresses the challenges of in-building and subterranean communication, making significant contributions to the overall efficiency and reliability of cellular networks.

Provider of drugs intended to treat cardiovascular disease. The company's biotechnology drugs include AHRO-001 is aimed at treating dyslipidemia and preventing atherosclerosis, enabling clients to get rapid and cost-effective achievement of clinical objectives.

Valtech Cardio Ltd. is a medical device company based in Or Yehuda, Israel, specializing in the development and manufacturing of cardiovascular devices aimed at treating mitral regurgitation and facilitating tricuspid valve repair and replacement. The company focuses on minimally invasive transcatheter heart valve technologies, allowing patients to avoid open-heart surgery. Its key products include the Cardioband System, which performs mitral valve reconstruction via transfemoral direct annuloplasty, and the Cardiovalve system, a transfemoral transseptal replacement option for the mitral valve. Additionally, Valtech offers the Cardinal adjustable annuloplasty ring, which allows surgeons to optimize the ring size during surgery. The company's pipeline includes innovative products such as Cardioband Tricuspid, designed for mitral regurgitation, and V-Chordal, an adjustable implanted chord for repairing valve prolapse. Founded in 2006, Valtech Cardio operates as a subsidiary of Zeppelin Zox Ltd. since January 2017.

Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

Neovasc Inc. is a specialty medical device company based in Richmond, Canada, focused on developing and manufacturing products for the cardiovascular market. The company offers innovative solutions, including the Tiara technology, designed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, intended for the treatment of refractory angina. While the Reducer has been commercially available in Europe since 2015, it is not yet available in the United States. The Tiara device is currently undergoing clinical investigation in various regions, including the United States, Canada, and Europe. Neovasc, incorporated in 2000 under a different name, leverages pericardial tissue processing and vascular product development to serve the growing needs of the cardiovascular industry.

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.

VisionCare Ophthalmic Technologies, Inc. is a specialty medical device company based in Saratoga, California, focused on the research, development, manufacture, and marketing of innovative implantable ophthalmic devices. The company primarily aims to enhance vision and quality of life for individuals suffering from untreatable retinal disorders, particularly end-stage age-related macular degeneration (AMD), which is a leading cause of blindness among older Americans. VisionCare's flagship product is the Implantable Miniature Telescope, the first FDA-approved device designed to improve vision in patients with advanced AMD. This telescope implant is a critical component of the CentraSight treatment program, which guides patients through the processes of diagnosis, surgical evaluation, and postoperative care. Founded in 1997, VisionCare is dedicated to helping patients reconnect with their daily lives and activities through its advanced visual prosthetic technologies.